ARCHIVES

House Committee Aims To Cut Markup On Office-Administered Cancer Drugs.

This article is from The Cancer Letter archive.

Vol. 27 No. 42 | November 16, 2001

Download PDF Visit The Full Archive

Related Articles

NCI Shifts Money to Save 100 Training Slots

July 14, 1989

Cancer Program Should Get $2 Billion A Year, Amos Says; “Feds Short On Money, Long of Regs”: Yarbro

March 25, 1983

Phase III Xilonix Study Halted Following Unscheduled Analysis

September 26, 2014

Blinatumomab Demonstrates High Response Rate in ALL

June 29, 2012

FDA Committee Oks AMSA for Group C List, Tables THC Request, Deadlocks On Estramustine NDA

July 3, 1981

As Leadership Changes Continue, Fontaine, Leach Get New Posts

January 17, 2014